APHB - AmpliPhi Biosciences Corporation

NYSE American - Nasdaq Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-12,110-12,838-18,838-516
Operating Activities, Cash Flows Provided By or Used In
Depreciation389374369330
Adjustments To Net Income1,9943,7297,210-9,437
Changes In Accounts Receivables----25
Changes In Liabilities343-838406-123.543
Changes In Inventories----
Changes In Other Operating Activities2381247-9.457
Total Cash Flow From Operating Activities-9,382-9,192-10,606-9,781
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-44-58-279-210
Investments----
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-44-58-279-210
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid---80-80
Sale Purchase of Stock----
Net Borrowings--815-100-100
Other Cash Flows from Financing Activities---173-173
Total Cash Flows From Financing Activities12,4518,6717,22612,780
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents3,025-579-3,6592,789